RA CAPITAL MANAGEMENT, L.P.

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
Boston, MA
CIK
0001346824
Alternate names
RA CAPITAL MANAGEMENT, LLC
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 62 6,402,499 ASND, IMGN, PCVX, LEGN 13F-HR 2/14/2024 000110465924023984
Q3 2023 1 37,587 CTKB NEW HOLDINGS 11/15/2023 000110465923118452
Q3 2023 65 5,042,131 ASND, LEGN, PCVX, IMGN 13F-HR 11/14/2023 000110465923118214
Q2 2023 54 5,296,462 ASND, LEGN, PCVX, DICE 13F-HR 8/14/2023 000110465923091405
Q1 2023 59 4,417,403 ASND, PCVX, DICE, ETNB 13F-HR 5/15/2023 000110465923060785
Q4 2022 70 4,930,699 ASND, PCVX, AVTE, DICE 13F-HR 2/14/2023 000110465923021847
Q3 2022 81 4,687,527 ASND, BIIB, CTKB, FORMA THERAPEUTICS HLDGS INC 13F-HR 11/14/2022 000110465922118654
Q2 2022 88 3,750,535 ASND, BIIB, CTKB, AVTE 13F-HR 8/15/2022 000110465922091331
Q1 2022 96 4,583,149 ASND, BIIB, AVTE, CTKB 13F-HR 5/16/2022 000110465922061386
Q4 2021 97 5,671,942 ASND, NVAX, ITOS, TVTX 13F-HR 2/14/2022 000110465922022807
Q3 2021 95 7,216,744 ASND, NVAX, ELYM, IVVD 13F-HR 11/15/2021 000110465921139249
Q2 2021 92 6,230,450 ASND, NVAX, FORMA THERAPEUTICS HLDGS INC, JANX 13F-HR 8/16/2021 000110465921106386
Q1 2021 82 6,631,817 ASND, NVAX, VOR, AVIR 13F-HR 5/17/2021 000110465921068149
Q4 2020 82 7,153,595 ASND, TGTX, NVAX, NKTX 13F-HR 2/16/2021 000110465921024161
Q3 2020 70 5,467,231 ASND, FORMA THERAPEUTICS HLDGS INC, CHEMOCENTRYX INC, PCVX 13F-HR 11/16/2020 000110465920125858
Q2 2020 57 5,131,829 ASND, FORMA THERAPEUTICS HLDGS INC, NVAX, CHEMOCENTRYX INC 13F-HR 8/14/2020 000110465920095562
Q1 2020 48 3,165,729 ASND, RARX, CHEMOCENTRYX INC, ARVN 13F-HR 5/15/2020 000110465920062663
Q4 2019 34 3,297,714 THOR, ASND, RARX, ARVN 13F-HR 2/14/2020 000110465920021928
Q3 2019 32 1,678,386 ASND, WVE, THOR, RARX 13F-HR 11/14/2019 000110465919064263
Q2 2019 25 1,862,830 ASND, WVE, ZGNX, RARX 13F-HR 8/14/2019 000114420419040093
Q1 2019 29 2,319,025 ASND, WVE, THOR, ZGNX 13F-HR 5/15/2019 000114420419026610
Q4 2018 25 1,717,985 WVE, ASND, THOR, ZGNX 13F-HR 2/14/2019 000114420419008235
Q3 2018 26 1,870,521 WVE, ASND, SLDB, ECYT 13F-HR 11/14/2018 000114420418059977
Q2 2018 27 1,540,247 WVE, ASND, SLDB, ECYT 13F-HR 8/14/2018 000114420418044712
Q1 2018 31 1,305,208 WVE, ASND, AVXS, MYOV 13F-HR 5/15/2018 000114420418028896
Q4 2017 27 1,195,149 WVE, ASND, AVXS, SAGE 13F-HR 2/14/2018 000114420418008963
Q3 2017 27 1,106,912 ASND, WVE, AVXS, BIOHAVEN PHARMACTL HLDG CO LTD 13F-HR 11/14/2017 000114420417059064
Q2 2017 22 871,430 ASND, WVE, AVXS, ACHN 13F-HR 8/14/2017 000114420417043212
Q1 2017 24 815,257 WVE, ASND, AVXS, ACHN 13F-HR 5/15/2017 000114420417027535
Q4 2016 26 687,184 WVE, ASND, AVXS, ACHN RESTATEMENT 2/16/2017 000114420417009568
Q4 2016 1 18,660 MYOV NEW HOLDINGS 2/16/2017 000114420417009569
Q3 2016 31 969,369 WVE, ACHN, ASND, AVXS 13F-HR 11/14/2016 000114420416134325
Q2 2016 32 722,235 WVE, ACHN, AXOVANT SCIENCES LTD, AVXS 13F-HR 8/15/2016 000114420416119492
Q1 2016 42 782,348 WVE, ACHN, AXOVANT SCIENCES LTD, ACRS 13F-HR 5/16/2016 000114420416102679
Q4 2015 37 1,010,538 ACHN, WVE, DYAX, AXOVANT SCIENCES LTD 13F-HR 2/16/2016 000114420416082766
Q3 2015 47 696,301 ACHN, AXOVANT SCIENCES LTD, DYAX, COLL 13F-HR 11/13/2015 000114420415065340
Q2 2015 59 994,105 AXOVANT SCIENCES LTD, ACHN, DYAX, SGMO calls 13F-HR 8/13/2015 000114420415049028
Q1 2015 57 1,006,949 SGMO calls, ACHN, DYAX, BCRX RESTATEMENT 7/6/2015 000114420415041113
Q4 2014 51 930,497 SGMO calls, BCRX, ACHN, RGLS 13F-HR 2/17/2015 000114420415010101
Q3 2014 46 846,275 ACAD calls, DYAX, BCRX, ACHN 13F-HR 11/14/2014 000114420414068823
Q2 2014 28 989,267 ACHN, ACAD calls, DYAX, SGMO calls 13F-HR 8/14/2014 000114420414050172
Q1 2014 35 1,394,409 GILD puts, ACAD calls, SGMO calls, SGMO 13F-HR 5/15/2014 000114420414031040
Q4 2013 31 858,468 ACAD calls, ACHN, SGMO, TXMD 13F-HR 2/14/2014 000114420414009252
Additional filings from Ra Capital Management, L.P. that have since been restated